Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

937 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Management of toxicities of immune checkpoint inhibitors.
Spain L, Diem S, Larkin J. Spain L, et al. Among authors: larkin j. Cancer Treat Rev. 2016 Mar;44:51-60. doi: 10.1016/j.ctrv.2016.02.001. Epub 2016 Feb 6. Cancer Treat Rev. 2016. PMID: 26874776 Review.
Kinase inhibitors in the treatment of renal cell carcinoma.
Larkin JM, Eisen T. Larkin JM, et al. Crit Rev Oncol Hematol. 2006 Dec;60(3):216-26. doi: 10.1016/j.critrevonc.2006.06.008. Epub 2006 Jul 24. Crit Rev Oncol Hematol. 2006. PMID: 16860997 Review.
A phase I/II study of lomustine and temozolomide in patients with cerebral metastases from malignant melanoma.
Larkin JM, Hughes SA, Beirne DA, Patel PM, Gibbens IM, Bate SC, Thomas K, Eisen TG, Gore ME. Larkin JM, et al. Br J Cancer. 2007 Jan 15;96(1):44-8. doi: 10.1038/sj.bjc.6603503. Epub 2006 Dec 5. Br J Cancer. 2007. PMID: 17146474 Free PMC article. Clinical Trial.
Drug insight: advances in renal cell carcinoma and the role of targeted therapies.
Larkin JM, Chowdhury S, Gore ME. Larkin JM, et al. Nat Clin Pract Oncol. 2007 Aug;4(8):470-9. doi: 10.1038/ncponc0901. Nat Clin Pract Oncol. 2007. PMID: 17657252 Review.
Sunitinib is superior to interferon alpha with respect to quality of life for patients with renal cell carcinoma.
Pickering LM, Pyle L, Larkin JM. Pickering LM, et al. Nat Clin Pract Oncol. 2009 Jan;6(1):6-7. doi: 10.1038/ncponc1283. Nat Clin Pract Oncol. 2009. PMID: 19096396
Malignant melanoma (metastatic).
Larkin J, Gore M. Larkin J, et al. BMJ Clin Evid. 2008 Aug 22;2008:1718. BMJ Clin Evid. 2008. PMID: 19445806 Free PMC article. Review.
Combination systemic therapy for advanced renal cell carcinoma.
Miller RE, Larkin JM. Miller RE, et al. Oncologist. 2009 Dec;14(12):1218-24. doi: 10.1634/theoncologist.2009-0105. Epub 2009 Nov 25. Oncologist. 2009. PMID: 19939892 Review.
Is advanced renal cell carcinoma becoming a chronic disease?
Larkin J, Gore M. Larkin J, et al. Lancet. 2010 Aug 21;376(9741):574-5. doi: 10.1016/S0140-6736(10)60816-1. Lancet. 2010. PMID: 20728740 No abstract available.
A phase I/II trial of sorafenib and infliximab in advanced renal cell carcinoma.
Larkin JM, Ferguson TR, Pickering LM, Edmonds K, James MG, Thomas K, Banerji U, Berns B, de Boer C, Gore ME. Larkin JM, et al. Br J Cancer. 2010 Oct 12;103(8):1149-53. doi: 10.1038/sj.bjc.6605889. Epub 2010 Sep 14. Br J Cancer. 2010. PMID: 20842130 Free PMC article. Clinical Trial.
Sunitinib for metastatic renal cell carcinoma.
Mukherji D, Larkin J, Pickering L. Mukherji D, et al. Among authors: larkin j. Future Oncol. 2010 Sep;6(9):1377-85. doi: 10.2217/fon.10.94. Future Oncol. 2010. PMID: 20919823 Review.
937 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback